• 14 June 2010
  • News
  • By

BIO People

Dr Shanthu Shantaram joins ABLE
Dr Shanthu Shantaram has been appointed as executive director of the Association of Biotech Led Enterprises (ABLE), India. He would take care of Special Interest Group on Agri-Biotechnology and would be based in New Delhi.

An eminent agri-expert and an advocate of GM crops in India, Dr Shantaram has been working as an independent consultant on biotechnology and biosafety and environmental risk assessment of GM crops with his own consulting firm, Biologistics International.

Earlier he worked as a senior research scholar of science, technology and environmental policy at Princeton University and also with Syngenta as a head of stakeholder relations and technology communications and then as a global head of regulatory compliance.

Dr Swati Piramal receives Global Empowerment Award
Dr Swati Piramal has received a special award at the Eleventh Asian Women of Achievement Awards in London on May 19, 2010. The Global Empowerment Award, which honors individuals whose vision inspires economic and social progress across the world, was presented by HRH Princess Michael of Kent and Amanda Mackenzie the chief marketing officer of Aviva.

In 2009, Dr Piramal became the first woman in the 90-year history of the Indian Chambers of Commerce, ASSOCHAM, to be elected president and she immediately chose 100 women to chair the chamber’s national sub-committees.

In 1998, she co-founded fledgling company Nicholas Laboratories, which has now grown into life sciences and healthcare multinational Piramal Group. With operations in India, the US and Europe, the company employs 10,000 people and sells products to over 100 countries. Her focus on ‘democratizing’ healthcare in India led her to set up a national diagnostic network.

She has also been the driving force behind many more medical initiatives in India. In 1983, she founded the Gopikrishna Piramal Memorial Hospital for underprivileged families with physically handicapped children and has written hundreds of papers on drugs pricing control, biotechnology regulation and data protection.

In 2006, she received the Chevalier de l’Ordre National du Merite (Knight of the Order of Merit) from the French President Jacques Chirac after being nominated by Forbes magazine as one of the 25 most powerful women in India.

SRC appoints Dr Bopanna as president
Semler Research Center (SRC), a subsidiary of Semler Group, has appointed Dr Krathish Bopanna as president and executive director. In this role, Dr Bopanna is responsible for the overall performance of SRC in India and the US across its diverse business segments.

Prior to joining SRC, Dr Bopanna was with Manipal Acunova as the senior vice president of Clinical Development. With over 15 years of pharmaceutical experience, he has served leading positions in companies like AstraZeneca and Tata Consulting Services.

Dr Abhijit Barve is COO of Clinigene
Biocon‘s clinical research arm Clinigene, announced the appointment of Dr Abhijit Barve as its chief operating officer (COO) with effect from May 1, 2010.
Abhijit has over 15 years of global drug development experience covering preclinical, early and late stage clinical development, clinical operations, regulatory and safety functions. During this timeframe, he has filed at least a dozen IND applications and has led the team that successfully negotiated the original and expanded labeling for Vaprisol.

“We are delighted to welcome Abhijit to Biocon and we are confident that his global business and operational experience will add great value to Clinigene’s ever evolving advancement in clinical development programs,” said Dr Kiran Mazumdar-Shaw, CMD, Biocon.

Manish Gupta to lead Strides’ pharma business
Strides Arcolab has appointed Manish Gupta as chief executive officer of its pharma business. The appointment follows the restructuring announced by the company in 2009 and the realignment of its business along three verticals – pharma, specialty and branded generics. With over 17 years of experience in leading and managing business and performance enhancement across the US, Europe and India, Gupta will be responsible for building and growing Strides Arcolab’s Pharma business globally.

He began his career with AF Ferguson and moved to Khandwala Securities before joining Wockhardt in 1998. His last position at the Wockhardt Group was as managing director. In his 12-year stint at Wockhardt, he handled 13 transactions (including five divestments) in the US, Europe and India.

Shobana becomes CFO of TAKE Solutions 

TAKE Solutions has appointed Shobana NS as the chief financial officer (CFO). She has over 15 years of expertise in strategic and operational aspects of management with continuous exposure and experience in supply chain management and general management roles. She began her journey with TAKE Solutions since its incorporation in 2000 and has been instrumental in the development of the organization. In this period of 10 years, she showcased her proficiency in both strategic and operational role and was vice president of finance and accounts before being promoted to her new role.

GVK Bio appoints Dr John Ellingboe as senior VP
Hyderabad-based leading CRO GVK Biosciences (GVK BIO) has appointed Dr John Ellingboe as senior vice president of Discovery Chemistry. He will report to Manni Kantipudi, president of GVK BIO.

Prior to joining GVK BIO, Dr Ellingboe worked with Wyeth Research and Pfizer for 25 years in senior scientific positions and has extensive background in medicinal chemistry and drug discovery.

While at Wyeth, he initiated and managed a large chemistry partnership with GVK BIO. He received his undergraduate degree in chemistry from Reed College and a PhD in Organic Chemistry from MIT. He has over 150 publications, presentations and patents to his credit.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email